Filing Details
- Accession Number:
- 0001127602-14-028335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-24 11:44:58
- Reporting Period:
- 2014-09-22
- Filing Date:
- 2014-09-24
- Accepted Time:
- 2014-09-24 11:44:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-22 | 65,234 | $75.63 | 120,817 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-22 | 60,534 | $104.64 | 60,283 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-22 | 4,700 | $105.58 | 55,583 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2014-09-22 | 65,234 | $0.00 | 0 | $75.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-05-07 | 2018-05-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 31,223 | Indirect | By grantor retained annuity trust |
| Common Stock | 27,296 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $104.6442 per share represents a weighted average of sales prices ranging from $104.24 to $105.23 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $105.5795 per share represents a weighted average of sales prices ranging from $105.26 to $105.93 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 05/7/2009 and is now fully exercisable.
Billionaire Hedge Funds
